JG
EBS icon

Jain Global’s Emergent Biosolutions EBS Stock Holding History

Jain Global’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-198,984
Closed -$1.65M – 1823
2026
Q1 		$1.65M Sell
198,984
-743,707
-79% -$7.7M 0.01% 721
2025
Q4 		$11.7M Buy
942,691
+433,984
+85% +$4.65M 0.06% 305
2025
Q3 		$4.49M Buy
+508,707
New +$3.96M 0.02% 387
2025
Q2 		– Sell
-63,914
Closed -$311K – 1295
2025
Q1 		$311K Buy
63,914
+7,641
+14% +$63.2K ﹤0.01% 669
2024
Q4 		$538K Buy
+56,273
New +$516K 0.02% 430

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Jain Global's EBS Position: Q2 2026 in Review

Jain Global sold out of Emergent Biosolutions (EBS) in Q2 2026, closing a stake of 198,984 shares — an estimated $1.65M sold.

Jain Global first reported a position in EBS in Q4 2024 and held it in 5 quarters. The position peaked at $11.7M in Q4 2025. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Jain Global reported no remaining Emergent Biosolutions position as of Q2 2026 after selling out during the quarter.
  • Jain Global sold 198,984 Emergent Biosolutions shares in Q2 2026, an estimated $1.65M.
  • Jain Global first reported a position in Emergent Biosolutions in Q4 2024 and held it in 5 quarters.
  • Jain Global's Emergent Biosolutions position peaked at $11.7M in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.